Amarin Corp Plcuk (AMRN) Long-Term Investments (2020 - 2023)

Amarin Corp Plcuk (AMRN) reported Long-Term Investments of $100000.0 for Q2 2023, down 99.12% year-over-year from $11.4 million in Q2 2022, and down 81.62% quarter-over-quarter from $544000.0 in Q1 2023.

Amarin Corp Plcuk (AMRN) Long-Term Investments (2020 - 2023) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 4 years of Long-Term Investments data on file, last reported at $100000.0 in Q2 2023.

  • Long-Term Investments for Q2 2023 came in at $100000.0, down 99.12% year-over-year; the trailing twelve-month figure through Jun 2023 was $100000.0 (down 99.12% YoY), and the FY2022 annual result was $1.3 million, down 96.36% from the prior year.
  • Long-Term Investments declined to $100000.0 in Q2 2023 per AMRN's latest filing, from $544000.0 in the prior quarter.
  • Over five years, Long-Term Investments peaked at $81.5 million in Q1 2020 and troughed at $100000.0 in Q2 2023.
  • A 4-year average of $29.0 million and a median of $25.4 million in 2021 frame the typical range for Long-Term Investments.
  • The sharpest annual moves came in 2022 and 2023: Long-Term Investments rose 11.24% in 2022, then slumped 99.12% in 2023.
  • A 4-year view of Long-Term Investments shows it stood at $62.5 million in 2020, then sank by 43.98% to $35.0 million in 2021, then plunged by 96.36% to $1.3 million in 2022, then plunged by 92.16% to $100000.0 in 2023.
  • Business Quant data shows AMRN's Long-Term Investments at $100000.0 in Q2 2023, $544000.0 in Q1 2023, and $1.3 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 133.47 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 3.12 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn -
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 268.00 Mn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 1.11 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 983.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 1.63 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 366.00 Mn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 100,000.00
Mar 31, 2023 544,000.00
Dec 31, 2022 1.28 Mn
Sep 30, 2022 2.30 Mn
Jun 30, 2022 11.40 Mn
Mar 31, 2022 26.70 Mn
Dec 31, 2021 35.00 Mn
Sep 30, 2021 38.80 Mn
Jun 30, 2021 14.16 Mn
Mar 31, 2021 24.00 Mn
Dec 31, 2020 62.47 Mn
Sep 30, 2020 46.09 Mn
Jun 30, 2020 61.04 Mn
Mar 31, 2020 81.50 Mn